134 related articles for article (PubMed ID: 16054168)
1. NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects.
Newaz M; Blanton A; Fidelis P; Oyekan A
Mutat Res; 2005 Nov; 579(1-2):163-71. PubMed ID: 16054168
[TBL] [Abstract][Full Text] [Related]
2. Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice.
Ighodaro I; Eric OK; Adebayo O
Niger J Physiol Sci; 2013 Dec; 28(2):127-33. PubMed ID: 24937386
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
Banks T; Oyekan A
J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
[TBL] [Abstract][Full Text] [Related]
4. Relationship between PPARalpha activation and NO on proximal tubular Na+ transport in the rat.
Newaz MA; Ranganna K; Oyekan AO
BMC Pharmacol; 2004 Feb; 4():1. PubMed ID: 15018640
[TBL] [Abstract][Full Text] [Related]
5. peroxisome proliferator-activated receptor alpha activation-mediated regulation of endothelin-1 production via nitric oxide and protein kinase C signaling pathways in piglet cerebral microvascular endothelial cell culture.
Yakubu MA; Nsaif RH; Oyekan AO
J Pharmacol Exp Ther; 2007 Feb; 320(2):774-81. PubMed ID: 17105827
[TBL] [Abstract][Full Text] [Related]
6. PPARα ligand clofibrate ameliorates blood pressure and vascular reactivity in spontaneously hypertensive rats.
Yousefipour Z; Newaz M
Acta Pharmacol Sin; 2014 Apr; 35(4):476-82. PubMed ID: 24562305
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hypoxia inducible factor/prolyl hydroxylase binding domain proteins 1 by PPARα and high salt diet.
Ozurumba E; Mathew O; Ranganna K; Choi M; Oyekan A
J Basic Clin Physiol Pharmacol; 2018 Mar; 29(2):165-173. PubMed ID: 29500923
[TBL] [Abstract][Full Text] [Related]
9. Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPARalpha null mice.
Obih P; Oyekan AO
Blood Press; 2008; 17(1):55-63. PubMed ID: 18568693
[TBL] [Abstract][Full Text] [Related]
10. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
[TBL] [Abstract][Full Text] [Related]
11. Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase.
Woods CG; Burns AM; Maki A; Bradford BU; Cunningham ML; Connor HD; Kadiiska MB; Mason RP; Peters JM; Rusyn I
Free Radic Biol Med; 2007 Feb; 42(3):335-42. PubMed ID: 17210446
[TBL] [Abstract][Full Text] [Related]
12. Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection.
Newaz MA; Yousefipour Z; Hercule H; Truong L; Oyekan A
Clin Exp Hypertens; 2003 Aug; 25(6):335-47. PubMed ID: 12940471
[TBL] [Abstract][Full Text] [Related]
13. Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.
Zhou Y; Luo P; Chang HH; Huang H; Yang T; Dong Z; Wang CY; Wang MH
Kidney Int; 2008 Oct; 74(8):1040-8. PubMed ID: 18596730
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent.
Newaz MA; Yousefipour Z; Oyekan A
J Cardiovasc Pharmacol; 2006 Sep; 48(3):88-94. PubMed ID: 17031261
[TBL] [Abstract][Full Text] [Related]
15. PPARalpha stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner.
Ibarra-Lara L; Cervantes-Pérez LG; Pérez-Severiano F; Del Valle L; Rubio-Ruíz E; Soria-Castro E; Pastelín-Hernández GS; Sánchez-Aguilar M; Martínez-Lazcano JC; Sánchez-Mendoza A
Eur J Pharmacol; 2010 Feb; 627(1-3):185-93. PubMed ID: 19857485
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: antioxidant protection by gamma-tocotrienol.
Newaz MA; Yousefipour Z; Nawal N; Adeeb N
J Physiol Pharmacol; 2003 Sep; 54(3):319-27. PubMed ID: 14566071
[TBL] [Abstract][Full Text] [Related]
17. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
[TBL] [Abstract][Full Text] [Related]
18. PPARα agonists regulate lipid metabolism and nitric oxide production and prevent placental overgrowth in term placentas from diabetic rats.
Martínez N; Kurtz M; Capobianco E; Higa R; White V; Jawerbaum A
J Mol Endocrinol; 2011 Aug; 47(1):1-12. PubMed ID: 21502283
[TBL] [Abstract][Full Text] [Related]
19. A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis.
Guelzim N; Mariotti F; Martin PG; Lasserre F; Pineau T; Hermier D
Amino Acids; 2011 Oct; 41(4):969-79. PubMed ID: 21063737
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
